Motif ID: Tlx2
Z-value: 1.145
Transcription factors associated with Tlx2:
| Gene Symbol | Entrez ID | Gene Name |
|---|---|---|
| Tlx2 | ENSMUSG00000068327.3 | Tlx2 |
Top targets:
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 3.8 | 11.3 | GO:0099548 | trans-synaptic signaling by nitric oxide(GO:0099548) |
| 3.1 | 9.4 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
| 2.8 | 8.5 | GO:0071603 | endothelial cell-cell adhesion(GO:0071603) |
| 2.5 | 7.6 | GO:0010752 | signal complex assembly(GO:0007172) regulation of cGMP-mediated signaling(GO:0010752) |
| 2.2 | 8.7 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
| 2.1 | 6.4 | GO:1902714 | negative regulation of interferon-gamma secretion(GO:1902714) |
| 2.0 | 5.9 | GO:1902938 | regulation of intracellular calcium activated chloride channel activity(GO:1902938) |
| 1.9 | 13.1 | GO:0061092 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
| 1.8 | 5.3 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
| 1.8 | 7.0 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
| 1.7 | 5.0 | GO:0001803 | antibody-dependent cellular cytotoxicity(GO:0001788) type III hypersensitivity(GO:0001802) regulation of type III hypersensitivity(GO:0001803) positive regulation of type III hypersensitivity(GO:0001805) |
| 1.6 | 4.9 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
| 1.4 | 5.8 | GO:0010511 | regulation of phosphatidylinositol biosynthetic process(GO:0010511) |
| 1.2 | 3.6 | GO:0001830 | trophectodermal cell fate commitment(GO:0001830) |
| 1.1 | 3.4 | GO:0051892 | negative regulation of cardioblast differentiation(GO:0051892) |
| 1.1 | 3.4 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
| 1.1 | 3.4 | GO:0070488 | neutrophil aggregation(GO:0070488) |
| 1.1 | 3.3 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
| 1.0 | 7.0 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
| 1.0 | 3.0 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
| 1.0 | 2.0 | GO:0034382 | chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
| 1.0 | 3.9 | GO:0097211 | prolactin secretion(GO:0070459) response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
| 0.9 | 3.7 | GO:0009597 | detection of virus(GO:0009597) |
| 0.9 | 2.8 | GO:0061588 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylserine scrambling(GO:0061589) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
| 0.9 | 4.6 | GO:0031580 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
| 0.9 | 4.3 | GO:0034436 | glycoprotein transport(GO:0034436) |
| 0.9 | 5.2 | GO:0003278 | apoptotic process involved in heart morphogenesis(GO:0003278) |
| 0.8 | 5.1 | GO:0097491 | trigeminal nerve morphogenesis(GO:0021636) trigeminal nerve structural organization(GO:0021637) trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) sympathetic neuron projection extension(GO:0097490) sympathetic neuron projection guidance(GO:0097491) semaphorin-plexin signaling pathway involved in axon guidance(GO:1902287) |
| 0.8 | 2.5 | GO:0090187 | zymogen granule exocytosis(GO:0070625) positive regulation of pancreatic juice secretion(GO:0090187) |
| 0.8 | 2.5 | GO:0051342 | regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
| 0.8 | 5.6 | GO:0070474 | positive regulation of uterine smooth muscle contraction(GO:0070474) |
| 0.8 | 4.7 | GO:0098712 | L-glutamate import across plasma membrane(GO:0098712) |
| 0.8 | 3.1 | GO:0002667 | lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) |
| 0.8 | 7.8 | GO:0061470 | interleukin-21 production(GO:0032625) T follicular helper cell differentiation(GO:0061470) interleukin-21 secretion(GO:0072619) |
| 0.8 | 2.3 | GO:0016598 | protein arginylation(GO:0016598) |
| 0.7 | 3.7 | GO:0032489 | regulation of Cdc42 protein signal transduction(GO:0032489) |
| 0.7 | 1.5 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
| 0.7 | 4.3 | GO:0006452 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
| 0.7 | 2.1 | GO:0070343 | white fat cell proliferation(GO:0070343) regulation of white fat cell proliferation(GO:0070350) |
| 0.7 | 4.9 | GO:0001955 | blood vessel maturation(GO:0001955) |
| 0.7 | 3.4 | GO:2001025 | positive regulation of response to drug(GO:2001025) |
| 0.7 | 4.0 | GO:0097646 | calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
| 0.6 | 1.9 | GO:1903048 | regulation of acetylcholine-gated cation channel activity(GO:1903048) |
| 0.6 | 1.8 | GO:2000987 | positive regulation of fear response(GO:1903367) positive regulation of behavioral fear response(GO:2000987) |
| 0.6 | 1.8 | GO:0061357 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) positive regulation of Wnt protein secretion(GO:0061357) |
| 0.6 | 5.2 | GO:1903874 | ferrous iron transmembrane transport(GO:1903874) |
| 0.6 | 1.1 | GO:0045963 | negative regulation of catecholamine metabolic process(GO:0045914) negative regulation of dopamine metabolic process(GO:0045963) |
| 0.5 | 3.3 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
| 0.5 | 4.8 | GO:0016198 | axon choice point recognition(GO:0016198) |
| 0.5 | 1.6 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
| 0.5 | 2.6 | GO:1903527 | positive regulation of membrane tubulation(GO:1903527) |
| 0.5 | 2.1 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
| 0.5 | 1.5 | GO:0061300 | cerebellum vasculature development(GO:0061300) |
| 0.5 | 2.0 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
| 0.5 | 2.0 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
| 0.5 | 1.5 | GO:0010641 | positive regulation of platelet-derived growth factor receptor signaling pathway(GO:0010641) |
| 0.5 | 5.9 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
| 0.5 | 1.4 | GO:0006296 | base-excision repair, AP site formation(GO:0006285) nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
| 0.5 | 1.9 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
| 0.4 | 13.0 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
| 0.4 | 3.0 | GO:0061718 | NADH regeneration(GO:0006735) regulation of anion channel activity(GO:0010359) canonical glycolysis(GO:0061621) glucose catabolic process to pyruvate(GO:0061718) |
| 0.4 | 1.7 | GO:0097298 | regulation of nucleus size(GO:0097298) |
| 0.4 | 0.8 | GO:2000192 | negative regulation of fatty acid transport(GO:2000192) |
| 0.4 | 4.5 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
| 0.4 | 1.1 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
| 0.4 | 4.8 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
| 0.4 | 2.5 | GO:1990416 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
| 0.4 | 3.9 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
| 0.4 | 5.0 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
| 0.4 | 1.1 | GO:0030827 | negative regulation of cGMP metabolic process(GO:0030824) negative regulation of cGMP biosynthetic process(GO:0030827) negative regulation of guanylate cyclase activity(GO:0031283) |
| 0.3 | 1.0 | GO:0035963 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
| 0.3 | 2.7 | GO:0002681 | somatic diversification of T cell receptor genes(GO:0002568) somatic recombination of T cell receptor gene segments(GO:0002681) T cell receptor V(D)J recombination(GO:0033153) |
| 0.3 | 1.7 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
| 0.3 | 1.0 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
| 0.3 | 1.6 | GO:1990034 | calcium ion export from cell(GO:1990034) |
| 0.3 | 2.3 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
| 0.3 | 2.0 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
| 0.3 | 1.0 | GO:0019858 | cytosine metabolic process(GO:0019858) |
| 0.3 | 1.9 | GO:0006108 | malate metabolic process(GO:0006108) |
| 0.3 | 2.5 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
| 0.3 | 3.1 | GO:0015838 | proline transport(GO:0015824) amino-acid betaine transport(GO:0015838) |
| 0.3 | 2.1 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
| 0.3 | 1.5 | GO:1900426 | positive regulation of defense response to bacterium(GO:1900426) |
| 0.3 | 0.9 | GO:0032627 | interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) |
| 0.3 | 2.1 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
| 0.3 | 0.8 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
| 0.3 | 1.1 | GO:2000974 | comma-shaped body morphogenesis(GO:0072049) negative regulation of pro-B cell differentiation(GO:2000974) |
| 0.3 | 3.2 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
| 0.3 | 4.5 | GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002504) |
| 0.3 | 3.2 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
| 0.3 | 1.3 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
| 0.3 | 1.8 | GO:1990504 | dense core granule exocytosis(GO:1990504) |
| 0.3 | 3.6 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
| 0.3 | 1.8 | GO:0007343 | egg activation(GO:0007343) |
| 0.2 | 2.5 | GO:1990118 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
| 0.2 | 1.2 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
| 0.2 | 0.5 | GO:2000016 | negative regulation of determination of dorsal identity(GO:2000016) |
| 0.2 | 1.1 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
| 0.2 | 1.3 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
| 0.2 | 0.2 | GO:0007521 | muscle cell fate determination(GO:0007521) |
| 0.2 | 1.0 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
| 0.2 | 1.9 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
| 0.2 | 0.4 | GO:2000017 | regulation of determination of dorsal identity(GO:2000015) positive regulation of determination of dorsal identity(GO:2000017) |
| 0.2 | 0.4 | GO:0032958 | inositol phosphate biosynthetic process(GO:0032958) |
| 0.2 | 3.6 | GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity(GO:0043552) |
| 0.2 | 2.2 | GO:2000580 | positive regulation of microtubule motor activity(GO:2000576) regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
| 0.2 | 1.4 | GO:0015862 | uridine transport(GO:0015862) |
| 0.2 | 4.1 | GO:0048266 | behavioral response to pain(GO:0048266) |
| 0.2 | 5.6 | GO:0018345 | protein palmitoylation(GO:0018345) |
| 0.2 | 1.9 | GO:0046085 | adenosine metabolic process(GO:0046085) |
| 0.2 | 1.9 | GO:0019243 | methylglyoxal metabolic process(GO:0009438) methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
| 0.2 | 3.0 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
| 0.2 | 2.6 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
| 0.2 | 3.7 | GO:0046321 | positive regulation of fatty acid oxidation(GO:0046321) |
| 0.2 | 2.0 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
| 0.2 | 0.7 | GO:0090521 | glomerular visceral epithelial cell migration(GO:0090521) |
| 0.2 | 1.9 | GO:0006020 | inositol metabolic process(GO:0006020) |
| 0.2 | 2.5 | GO:0014049 | positive regulation of glutamate secretion(GO:0014049) |
| 0.2 | 0.3 | GO:0046110 | xanthine metabolic process(GO:0046110) |
| 0.2 | 4.0 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
| 0.2 | 3.7 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
| 0.2 | 3.9 | GO:0006907 | pinocytosis(GO:0006907) |
| 0.2 | 3.1 | GO:0032060 | bleb assembly(GO:0032060) |
| 0.2 | 3.5 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
| 0.2 | 1.1 | GO:0060347 | heart trabecula formation(GO:0060347) |
| 0.2 | 1.2 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
| 0.1 | 0.3 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
| 0.1 | 7.6 | GO:0034605 | cellular response to heat(GO:0034605) |
| 0.1 | 1.9 | GO:0099645 | receptor diffusion trapping(GO:0098953) postsynaptic neurotransmitter receptor diffusion trapping(GO:0098970) neurotransmitter receptor diffusion trapping(GO:0099628) protein localization to postsynaptic specialization membrane(GO:0099633) neurotransmitter receptor localization to postsynaptic specialization membrane(GO:0099645) |
| 0.1 | 0.6 | GO:0015744 | succinate transport(GO:0015744) |
| 0.1 | 0.7 | GO:0045056 | transcytosis(GO:0045056) |
| 0.1 | 0.7 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
| 0.1 | 3.4 | GO:0008340 | determination of adult lifespan(GO:0008340) |
| 0.1 | 1.3 | GO:0046512 | sphingosine biosynthetic process(GO:0046512) sphingoid biosynthetic process(GO:0046520) |
| 0.1 | 0.5 | GO:0035752 | lysosomal lumen pH elevation(GO:0035752) |
| 0.1 | 6.8 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
| 0.1 | 2.1 | GO:0000338 | protein deneddylation(GO:0000338) |
| 0.1 | 0.5 | GO:0072592 | oxygen metabolic process(GO:0072592) |
| 0.1 | 0.2 | GO:0045918 | negative regulation of cytolysis(GO:0045918) |
| 0.1 | 1.3 | GO:0034389 | lipid particle organization(GO:0034389) |
| 0.1 | 1.3 | GO:0006228 | UTP biosynthetic process(GO:0006228) |
| 0.1 | 0.6 | GO:0035720 | intraciliary anterograde transport(GO:0035720) |
| 0.1 | 8.9 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
| 0.1 | 0.3 | GO:0070889 | platelet alpha granule organization(GO:0070889) regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) |
| 0.1 | 0.6 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
| 0.1 | 3.7 | GO:0050829 | defense response to Gram-negative bacterium(GO:0050829) |
| 0.1 | 3.4 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
| 0.1 | 0.4 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
| 0.1 | 0.2 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) terminal web assembly(GO:1902896) |
| 0.1 | 0.3 | GO:0046013 | regulation of T cell homeostatic proliferation(GO:0046013) negative regulation of T-helper 17 type immune response(GO:2000317) regulation of T-helper 17 cell differentiation(GO:2000319) negative regulation of T-helper 17 cell differentiation(GO:2000320) |
| 0.1 | 1.0 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
| 0.1 | 2.0 | GO:0045026 | plasma membrane fusion(GO:0045026) |
| 0.1 | 5.6 | GO:0032543 | mitochondrial translation(GO:0032543) |
| 0.1 | 1.1 | GO:0050909 | sensory perception of taste(GO:0050909) |
| 0.1 | 0.4 | GO:0002934 | desmosome organization(GO:0002934) |
| 0.1 | 0.4 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
| 0.1 | 0.3 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
| 0.1 | 0.2 | GO:0032497 | detection of lipopolysaccharide(GO:0032497) |
| 0.1 | 1.5 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
| 0.1 | 2.3 | GO:0034629 | cellular protein complex localization(GO:0034629) |
| 0.1 | 0.2 | GO:0060745 | mammary gland branching involved in pregnancy(GO:0060745) |
| 0.1 | 2.5 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
| 0.1 | 0.5 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
| 0.1 | 0.2 | GO:0032570 | response to progesterone(GO:0032570) |
| 0.1 | 4.4 | GO:0007019 | microtubule depolymerization(GO:0007019) |
| 0.1 | 1.7 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
| 0.1 | 5.6 | GO:0072583 | clathrin-mediated endocytosis(GO:0072583) |
| 0.1 | 5.1 | GO:0046847 | filopodium assembly(GO:0046847) |
| 0.1 | 1.4 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
| 0.1 | 0.4 | GO:0007021 | tubulin complex assembly(GO:0007021) |
| 0.1 | 0.4 | GO:0098706 | ferric iron import(GO:0033216) iron ion import into cell(GO:0097459) ferric iron import into cell(GO:0097461) ferric iron import across plasma membrane(GO:0098706) iron ion import across plasma membrane(GO:0098711) |
| 0.1 | 1.0 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
| 0.1 | 1.3 | GO:0051894 | positive regulation of focal adhesion assembly(GO:0051894) positive regulation of adherens junction organization(GO:1903393) |
| 0.1 | 2.9 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
| 0.1 | 0.3 | GO:0035509 | negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) |
| 0.1 | 1.5 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
| 0.1 | 1.8 | GO:0009303 | rRNA transcription(GO:0009303) |
| 0.1 | 1.0 | GO:1903861 | positive regulation of dendrite extension(GO:1903861) |
| 0.1 | 3.7 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
| 0.1 | 0.5 | GO:0009404 | toxin metabolic process(GO:0009404) |
| 0.1 | 0.3 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
| 0.1 | 1.1 | GO:0003016 | respiratory system process(GO:0003016) |
| 0.0 | 0.7 | GO:0001516 | prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
| 0.0 | 0.6 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
| 0.0 | 0.5 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
| 0.0 | 0.6 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
| 0.0 | 4.3 | GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) |
| 0.0 | 0.5 | GO:0007220 | Notch receptor processing(GO:0007220) |
| 0.0 | 2.5 | GO:2001238 | positive regulation of extrinsic apoptotic signaling pathway(GO:2001238) |
| 0.0 | 0.1 | GO:0006566 | threonine metabolic process(GO:0006566) |
| 0.0 | 0.2 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
| 0.0 | 0.4 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
| 0.0 | 1.6 | GO:0060291 | long-term synaptic potentiation(GO:0060291) |
| 0.0 | 1.4 | GO:0032456 | endocytic recycling(GO:0032456) |
| 0.0 | 0.4 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
| 0.0 | 1.0 | GO:0007097 | nuclear migration(GO:0007097) establishment of nucleus localization(GO:0040023) |
| 0.0 | 0.6 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
| 0.0 | 0.3 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
| 0.0 | 0.2 | GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
| 0.0 | 2.2 | GO:0002181 | cytoplasmic translation(GO:0002181) |
| 0.0 | 0.3 | GO:0034551 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
| 0.0 | 1.5 | GO:0007584 | response to nutrient(GO:0007584) |
| 0.0 | 0.3 | GO:1903301 | fructose 2,6-bisphosphate metabolic process(GO:0006003) positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
| 0.0 | 1.5 | GO:0045670 | regulation of osteoclast differentiation(GO:0045670) |
| 0.0 | 3.4 | GO:0016052 | carbohydrate catabolic process(GO:0016052) |
| 0.0 | 0.9 | GO:0007093 | mitotic cell cycle checkpoint(GO:0007093) |
| 0.0 | 0.3 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
| 0.0 | 0.1 | GO:0019389 | glucuronoside metabolic process(GO:0019389) |
| 0.0 | 1.3 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
| 0.0 | 0.1 | GO:0015786 | UDP-glucose transport(GO:0015786) |
| 0.0 | 0.6 | GO:0046928 | regulation of neurotransmitter secretion(GO:0046928) |
| 0.0 | 0.7 | GO:0036075 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
| 0.0 | 0.6 | GO:0061462 | protein localization to lysosome(GO:0061462) |
| 0.0 | 0.4 | GO:1900153 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
| 0.0 | 0.3 | GO:0055090 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
| 0.0 | 2.1 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
| 0.0 | 0.7 | GO:0007099 | centriole replication(GO:0007099) |
| 0.0 | 1.3 | GO:0006959 | humoral immune response(GO:0006959) |
| 0.0 | 1.0 | GO:0007566 | embryo implantation(GO:0007566) |
| 0.0 | 0.7 | GO:0015985 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
| 0.0 | 0.2 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
| 0.0 | 1.0 | GO:0043627 | response to estrogen(GO:0043627) |
| 0.0 | 0.1 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
| 0.0 | 0.6 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
| 0.0 | 0.1 | GO:0009249 | protein lipoylation(GO:0009249) |
| 0.0 | 0.1 | GO:1901799 | negative regulation of proteasomal protein catabolic process(GO:1901799) |
| 0.0 | 0.2 | GO:0034453 | microtubule anchoring(GO:0034453) |
| 0.0 | 0.1 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
| 0.0 | 0.4 | GO:0006270 | DNA replication initiation(GO:0006270) |
| 0.0 | 0.3 | GO:0046460 | triglyceride biosynthetic process(GO:0019432) neutral lipid biosynthetic process(GO:0046460) acylglycerol biosynthetic process(GO:0046463) |
| 0.0 | 0.4 | GO:1900087 | positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) |
| 0.0 | 0.1 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
| 0.0 | 1.4 | GO:0002244 | hematopoietic progenitor cell differentiation(GO:0002244) |
| 0.0 | 0.3 | GO:0061001 | regulation of dendritic spine morphogenesis(GO:0061001) |
| 0.0 | 0.3 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
| 0.0 | 0.1 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
| 0.0 | 0.1 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.3 | 3.9 | GO:0005940 | septin ring(GO:0005940) |
| 0.9 | 3.7 | GO:0097447 | dendritic tree(GO:0097447) |
| 0.9 | 16.3 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
| 0.8 | 4.0 | GO:1903440 | calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
| 0.6 | 6.8 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
| 0.6 | 5.3 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
| 0.6 | 7.6 | GO:0070852 | cell body fiber(GO:0070852) |
| 0.6 | 7.5 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
| 0.5 | 1.5 | GO:0042720 | mitochondrial inner membrane peptidase complex(GO:0042720) |
| 0.5 | 2.5 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
| 0.4 | 7.6 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
| 0.4 | 2.0 | GO:0000308 | cytoplasmic cyclin-dependent protein kinase holoenzyme complex(GO:0000308) |
| 0.4 | 5.9 | GO:0097449 | astrocyte projection(GO:0097449) |
| 0.4 | 4.3 | GO:0005642 | annulate lamellae(GO:0005642) |
| 0.3 | 2.1 | GO:0045179 | apical cortex(GO:0045179) |
| 0.3 | 7.0 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
| 0.3 | 1.4 | GO:1990745 | EARP complex(GO:1990745) |
| 0.3 | 1.3 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
| 0.3 | 6.5 | GO:0000242 | pericentriolar material(GO:0000242) |
| 0.3 | 4.1 | GO:0005614 | interstitial matrix(GO:0005614) |
| 0.2 | 2.0 | GO:0042629 | mast cell granule(GO:0042629) |
| 0.2 | 2.9 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
| 0.2 | 1.7 | GO:0005638 | lamin filament(GO:0005638) |
| 0.2 | 5.3 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
| 0.2 | 2.5 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
| 0.2 | 4.6 | GO:0032279 | asymmetric synapse(GO:0032279) |
| 0.2 | 3.4 | GO:1990635 | proximal dendrite(GO:1990635) |
| 0.2 | 1.0 | GO:0005827 | polar microtubule(GO:0005827) |
| 0.2 | 1.9 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
| 0.2 | 0.7 | GO:0071942 | XPC complex(GO:0071942) |
| 0.2 | 4.4 | GO:0005921 | gap junction(GO:0005921) |
| 0.2 | 0.5 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
| 0.2 | 3.6 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
| 0.2 | 2.8 | GO:0030008 | TRAPP complex(GO:0030008) |
| 0.2 | 3.3 | GO:0031527 | filopodium membrane(GO:0031527) |
| 0.2 | 0.2 | GO:0097524 | sperm plasma membrane(GO:0097524) |
| 0.2 | 1.4 | GO:0000439 | core TFIIH complex(GO:0000439) |
| 0.2 | 0.8 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
| 0.2 | 5.3 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
| 0.2 | 3.3 | GO:0043218 | compact myelin(GO:0043218) |
| 0.1 | 3.0 | GO:0097228 | sperm principal piece(GO:0097228) |
| 0.1 | 1.1 | GO:0070652 | HAUS complex(GO:0070652) |
| 0.1 | 2.0 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
| 0.1 | 1.3 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
| 0.1 | 0.8 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
| 0.1 | 1.7 | GO:0042405 | nuclear inclusion body(GO:0042405) |
| 0.1 | 3.8 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
| 0.1 | 4.9 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
| 0.1 | 1.9 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
| 0.1 | 3.4 | GO:0055038 | recycling endosome membrane(GO:0055038) |
| 0.1 | 0.8 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
| 0.1 | 0.7 | GO:0042613 | MHC class II protein complex(GO:0042613) |
| 0.1 | 0.5 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
| 0.1 | 0.6 | GO:0071986 | Ragulator complex(GO:0071986) |
| 0.1 | 0.8 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
| 0.1 | 1.2 | GO:0031209 | SCAR complex(GO:0031209) |
| 0.1 | 3.7 | GO:0034707 | chloride channel complex(GO:0034707) |
| 0.1 | 8.3 | GO:0045111 | intermediate filament cytoskeleton(GO:0045111) |
| 0.1 | 0.3 | GO:0043540 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase complex(GO:0043540) |
| 0.1 | 3.1 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
| 0.1 | 1.2 | GO:0072546 | ER membrane protein complex(GO:0072546) |
| 0.1 | 0.4 | GO:0005859 | muscle myosin complex(GO:0005859) |
| 0.1 | 1.8 | GO:0034451 | centriolar satellite(GO:0034451) |
| 0.1 | 6.2 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
| 0.1 | 2.7 | GO:0005719 | nuclear euchromatin(GO:0005719) |
| 0.1 | 4.4 | GO:0000315 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
| 0.1 | 1.5 | GO:0010369 | chromocenter(GO:0010369) |
| 0.1 | 1.1 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
| 0.1 | 3.9 | GO:0034704 | calcium channel complex(GO:0034704) |
| 0.1 | 0.6 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
| 0.1 | 2.6 | GO:0001772 | immunological synapse(GO:0001772) |
| 0.1 | 13.5 | GO:0005802 | trans-Golgi network(GO:0005802) |
| 0.1 | 6.1 | GO:0043195 | terminal bouton(GO:0043195) |
| 0.1 | 0.3 | GO:0070876 | SOSS complex(GO:0070876) |
| 0.1 | 0.5 | GO:0070765 | gamma-secretase complex(GO:0070765) |
| 0.1 | 0.2 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
| 0.1 | 0.9 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
| 0.1 | 0.6 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
| 0.1 | 11.0 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
| 0.1 | 6.4 | GO:0031225 | anchored component of membrane(GO:0031225) |
| 0.1 | 1.8 | GO:0042734 | presynaptic membrane(GO:0042734) |
| 0.1 | 0.6 | GO:0005687 | U4 snRNP(GO:0005687) |
| 0.1 | 0.8 | GO:0000346 | transcription export complex(GO:0000346) |
| 0.1 | 3.1 | GO:0014704 | intercalated disc(GO:0014704) |
| 0.0 | 0.4 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
| 0.0 | 0.7 | GO:0005869 | dynactin complex(GO:0005869) |
| 0.0 | 0.2 | GO:1990357 | terminal web(GO:1990357) |
| 0.0 | 0.6 | GO:0097542 | ciliary tip(GO:0097542) |
| 0.0 | 0.7 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
| 0.0 | 2.8 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
| 0.0 | 0.4 | GO:0016272 | prefoldin complex(GO:0016272) |
| 0.0 | 1.3 | GO:0045335 | phagocytic vesicle(GO:0045335) |
| 0.0 | 1.0 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
| 0.0 | 0.9 | GO:0030673 | axolemma(GO:0030673) |
| 0.0 | 0.7 | GO:0044447 | axoneme part(GO:0044447) |
| 0.0 | 2.9 | GO:0005778 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
| 0.0 | 2.3 | GO:0055037 | recycling endosome(GO:0055037) |
| 0.0 | 3.9 | GO:0000118 | histone deacetylase complex(GO:0000118) |
| 0.0 | 1.2 | GO:0008180 | COP9 signalosome(GO:0008180) |
| 0.0 | 0.3 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) |
| 0.0 | 0.4 | GO:0042555 | MCM complex(GO:0042555) |
| 0.0 | 0.4 | GO:0042612 | MHC class I protein complex(GO:0042612) |
| 0.0 | 4.6 | GO:0014069 | postsynaptic density(GO:0014069) |
| 0.0 | 0.4 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
| 0.0 | 1.7 | GO:0030017 | sarcomere(GO:0030017) |
| 0.0 | 1.2 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
| 0.0 | 0.7 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
| 0.0 | 3.4 | GO:0031965 | nuclear membrane(GO:0031965) |
| 0.0 | 1.9 | GO:0098794 | postsynapse(GO:0098794) |
| 0.0 | 0.1 | GO:0000243 | commitment complex(GO:0000243) |
| 0.0 | 0.1 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
| 0.0 | 2.3 | GO:0045121 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
| 0.0 | 0.6 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
| 0.0 | 2.0 | GO:0043209 | myelin sheath(GO:0043209) |
| 0.0 | 0.8 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
| 0.0 | 1.6 | GO:0043235 | receptor complex(GO:0043235) |
| 0.0 | 10.9 | GO:0005794 | Golgi apparatus(GO:0005794) |
| 0.0 | 0.8 | GO:0005923 | bicellular tight junction(GO:0005923) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.2 | 13.0 | GO:0043426 | MRF binding(GO:0043426) |
| 1.9 | 5.8 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) |
| 1.5 | 4.5 | GO:0043758 | acetate-CoA ligase (ADP-forming) activity(GO:0043758) |
| 1.5 | 5.9 | GO:0001639 | PLC activating G-protein coupled glutamate receptor activity(GO:0001639) A2A adenosine receptor binding(GO:0031687) G-protein coupled receptor activity involved in regulation of postsynaptic membrane potential(GO:0099530) |
| 1.5 | 4.4 | GO:0016160 | alpha-amylase activity(GO:0004556) amylase activity(GO:0016160) |
| 1.4 | 16.3 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
| 1.2 | 7.0 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
| 1.1 | 5.6 | GO:0042610 | CD8 receptor binding(GO:0042610) |
| 1.1 | 6.4 | GO:0016936 | galactoside binding(GO:0016936) |
| 1.0 | 3.0 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
| 1.0 | 5.0 | GO:0019770 | IgG receptor activity(GO:0019770) |
| 1.0 | 2.9 | GO:0034437 | very-low-density lipoprotein particle binding(GO:0034189) glycoprotein transporter activity(GO:0034437) |
| 0.9 | 7.6 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
| 0.9 | 7.0 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
| 0.8 | 2.5 | GO:0036004 | GAF domain binding(GO:0036004) |
| 0.8 | 4.0 | GO:0097643 | amylin receptor activity(GO:0097643) |
| 0.7 | 4.7 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) |
| 0.6 | 3.0 | GO:0008865 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
| 0.6 | 12.2 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
| 0.6 | 14.4 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
| 0.6 | 4.6 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
| 0.6 | 3.4 | GO:0050786 | arachidonic acid binding(GO:0050544) RAGE receptor binding(GO:0050786) |
| 0.6 | 3.9 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
| 0.5 | 5.9 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
| 0.5 | 3.7 | GO:0001515 | opioid peptide activity(GO:0001515) |
| 0.5 | 6.0 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
| 0.5 | 2.0 | GO:0035473 | lipase binding(GO:0035473) |
| 0.5 | 5.4 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
| 0.4 | 0.4 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
| 0.4 | 1.6 | GO:0046870 | cadmium ion binding(GO:0046870) |
| 0.4 | 2.4 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
| 0.4 | 3.1 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
| 0.4 | 1.9 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
| 0.4 | 1.1 | GO:0008527 | taste receptor activity(GO:0008527) |
| 0.4 | 1.5 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
| 0.4 | 1.1 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
| 0.4 | 1.1 | GO:0016206 | catechol O-methyltransferase activity(GO:0016206) |
| 0.4 | 1.5 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
| 0.4 | 2.5 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
| 0.3 | 5.5 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
| 0.3 | 5.1 | GO:0045499 | chemorepellent activity(GO:0045499) |
| 0.3 | 2.5 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
| 0.3 | 2.5 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
| 0.3 | 1.9 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
| 0.3 | 2.5 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
| 0.3 | 8.7 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
| 0.3 | 2.1 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
| 0.3 | 1.4 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
| 0.3 | 9.4 | GO:0071837 | HMG box domain binding(GO:0071837) |
| 0.3 | 3.3 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
| 0.3 | 4.2 | GO:0017070 | U6 snRNA binding(GO:0017070) |
| 0.3 | 2.3 | GO:0034046 | poly(G) binding(GO:0034046) |
| 0.3 | 2.8 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
| 0.2 | 2.2 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
| 0.2 | 3.9 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
| 0.2 | 1.9 | GO:0031811 | G-protein coupled nucleotide receptor binding(GO:0031811) P2Y1 nucleotide receptor binding(GO:0031812) |
| 0.2 | 1.1 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
| 0.2 | 1.3 | GO:0017040 | ceramidase activity(GO:0017040) |
| 0.2 | 1.9 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
| 0.2 | 3.7 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
| 0.2 | 3.7 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
| 0.2 | 1.0 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
| 0.2 | 7.8 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
| 0.2 | 0.6 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
| 0.2 | 5.6 | GO:0019707 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
| 0.2 | 1.9 | GO:0022848 | acetylcholine-gated cation channel activity(GO:0022848) |
| 0.2 | 2.0 | GO:0031628 | opioid receptor binding(GO:0031628) |
| 0.2 | 2.9 | GO:0004385 | guanylate kinase activity(GO:0004385) |
| 0.2 | 1.1 | GO:0050694 | galactose 3-O-sulfotransferase activity(GO:0050694) |
| 0.2 | 0.9 | GO:0031996 | thioesterase binding(GO:0031996) |
| 0.2 | 2.7 | GO:0030955 | potassium ion binding(GO:0030955) |
| 0.2 | 0.7 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
| 0.2 | 2.0 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
| 0.2 | 0.6 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) prostaglandin-E synthase activity(GO:0050220) |
| 0.2 | 3.8 | GO:0042287 | MHC protein binding(GO:0042287) |
| 0.2 | 2.6 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
| 0.2 | 0.9 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
| 0.2 | 4.5 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
| 0.1 | 0.7 | GO:0019865 | immunoglobulin binding(GO:0019865) |
| 0.1 | 0.8 | GO:0070492 | sialic acid binding(GO:0033691) oligosaccharide binding(GO:0070492) |
| 0.1 | 0.4 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
| 0.1 | 4.3 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
| 0.1 | 2.1 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
| 0.1 | 0.7 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
| 0.1 | 0.4 | GO:0008823 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
| 0.1 | 1.2 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
| 0.1 | 2.9 | GO:0097602 | cullin family protein binding(GO:0097602) |
| 0.1 | 1.3 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
| 0.1 | 1.3 | GO:0051018 | protein kinase A binding(GO:0051018) |
| 0.1 | 2.5 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
| 0.1 | 2.4 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
| 0.1 | 0.3 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
| 0.1 | 1.7 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
| 0.1 | 6.9 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
| 0.1 | 0.4 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
| 0.1 | 2.1 | GO:0043274 | phospholipase binding(GO:0043274) |
| 0.1 | 0.7 | GO:1990405 | protein antigen binding(GO:1990405) |
| 0.1 | 0.4 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
| 0.1 | 10.1 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
| 0.1 | 3.6 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
| 0.1 | 1.5 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
| 0.1 | 2.1 | GO:0001968 | fibronectin binding(GO:0001968) |
| 0.1 | 10.7 | GO:0030165 | PDZ domain binding(GO:0030165) |
| 0.1 | 1.0 | GO:0001618 | virus receptor activity(GO:0001618) |
| 0.1 | 0.3 | GO:0043546 | molybdenum ion binding(GO:0030151) molybdopterin cofactor binding(GO:0043546) |
| 0.1 | 0.4 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
| 0.1 | 0.3 | GO:0005093 | Rab GDP-dissociation inhibitor activity(GO:0005093) |
| 0.1 | 0.2 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
| 0.1 | 1.5 | GO:0017160 | Ral GTPase binding(GO:0017160) |
| 0.1 | 0.7 | GO:1990446 | U1 snRNP binding(GO:1990446) |
| 0.1 | 0.2 | GO:0031798 | type 1 metabotropic glutamate receptor binding(GO:0031798) RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding(GO:0038052) |
| 0.1 | 1.3 | GO:0017049 | GTP-Rho binding(GO:0017049) |
| 0.1 | 0.8 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
| 0.1 | 2.8 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
| 0.1 | 1.6 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
| 0.1 | 5.2 | GO:0015171 | amino acid transmembrane transporter activity(GO:0015171) |
| 0.1 | 10.0 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
| 0.1 | 0.2 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
| 0.1 | 1.0 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
| 0.1 | 1.4 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
| 0.1 | 4.8 | GO:0005525 | GTP binding(GO:0005525) |
| 0.1 | 3.6 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
| 0.0 | 3.0 | GO:0019003 | GDP binding(GO:0019003) |
| 0.0 | 0.1 | GO:0016979 | lipoate-protein ligase activity(GO:0016979) |
| 0.0 | 19.4 | GO:0005509 | calcium ion binding(GO:0005509) |
| 0.0 | 3.7 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
| 0.0 | 1.0 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
| 0.0 | 1.7 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
| 0.0 | 0.3 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
| 0.0 | 1.1 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
| 0.0 | 1.7 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
| 0.0 | 1.5 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
| 0.0 | 1.9 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
| 0.0 | 1.5 | GO:0004896 | cytokine receptor activity(GO:0004896) |
| 0.0 | 0.4 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
| 0.0 | 0.3 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
| 0.0 | 0.8 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
| 0.0 | 0.4 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
| 0.0 | 1.1 | GO:0019843 | rRNA binding(GO:0019843) |
| 0.0 | 2.3 | GO:0008565 | protein transporter activity(GO:0008565) |
| 0.0 | 0.4 | GO:0003688 | DNA replication origin binding(GO:0003688) |
| 0.0 | 0.7 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
| 0.0 | 0.5 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
| 0.0 | 2.7 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
| 0.0 | 1.5 | GO:0016209 | antioxidant activity(GO:0016209) |
| 0.0 | 1.5 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
| 0.0 | 1.6 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
| 0.0 | 0.1 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
| 0.0 | 4.9 | GO:0003924 | GTPase activity(GO:0003924) |
| 0.0 | 0.6 | GO:0050136 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
| 0.0 | 2.4 | GO:0047485 | protein N-terminus binding(GO:0047485) |
| 0.0 | 0.5 | GO:0016278 | lysine N-methyltransferase activity(GO:0016278) protein-lysine N-methyltransferase activity(GO:0016279) |
| 0.0 | 0.1 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
| 0.0 | 0.8 | GO:0004521 | endoribonuclease activity(GO:0004521) |
| 0.0 | 0.6 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
| 0.0 | 0.8 | GO:0016860 | intramolecular oxidoreductase activity(GO:0016860) |
| 0.0 | 0.1 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
| 0.0 | 1.3 | GO:0005178 | integrin binding(GO:0005178) |
| 0.0 | 0.0 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
| 0.0 | 0.2 | GO:0001848 | complement binding(GO:0001848) |
| 0.0 | 0.2 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
| 0.0 | 1.6 | GO:0016810 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds(GO:0016810) |
| 0.0 | 2.7 | GO:0008022 | protein C-terminus binding(GO:0008022) |
| 0.0 | 0.3 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
| 0.0 | 0.5 | GO:0046875 | ephrin receptor binding(GO:0046875) |
| 0.0 | 0.3 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
| 0.0 | 0.7 | GO:0031491 | nucleosome binding(GO:0031491) |
| 0.0 | 1.2 | GO:0001047 | core promoter binding(GO:0001047) |
| 0.0 | 0.2 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
Gene overrepresentation in C2:CP category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.7 | 13.4 | PID_CIRCADIAN_PATHWAY | Circadian rhythm pathway |
| 0.5 | 7.2 | PID_INTEGRIN2_PATHWAY | Beta2 integrin cell surface interactions |
| 0.4 | 7.6 | PID_LPA4_PATHWAY | LPA4-mediated signaling events |
| 0.4 | 15.6 | SA_PTEN_PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
| 0.3 | 10.3 | PID_ARF_3PATHWAY | Arf1 pathway |
| 0.3 | 5.7 | PID_AVB3_OPN_PATHWAY | Osteopontin-mediated events |
| 0.2 | 5.6 | PID_NFKAPPAB_ATYPICAL_PATHWAY | Atypical NF-kappaB pathway |
| 0.2 | 3.2 | PID_S1P_S1P2_PATHWAY | S1P2 pathway |
| 0.2 | 2.9 | PID_UPA_UPAR_PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
| 0.2 | 5.9 | PID_INTEGRIN_A4B1_PATHWAY | Alpha4 beta1 integrin signaling events |
| 0.2 | 3.6 | PID_TOLL_ENDOGENOUS_PATHWAY | Endogenous TLR signaling |
| 0.2 | 4.1 | PID_IL12_STAT4_PATHWAY | IL12 signaling mediated by STAT4 |
| 0.1 | 5.4 | ST_WNT_BETA_CATENIN_PATHWAY | Wnt/beta-catenin Pathway |
| 0.1 | 5.1 | PID_MAPK_TRK_PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
| 0.1 | 16.1 | NABA_ECM_AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
| 0.1 | 16.5 | NABA_ECM_GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
| 0.1 | 3.6 | PID_NCADHERIN_PATHWAY | N-cadherin signaling events |
| 0.1 | 2.1 | PID_IL1_PATHWAY | IL1-mediated signaling events |
| 0.1 | 1.9 | ST_GA12_PATHWAY | G alpha 12 Pathway |
| 0.1 | 1.1 | PID_ALK2_PATHWAY | ALK2 signaling events |
| 0.1 | 2.4 | PID_HIF1_TFPATHWAY | HIF-1-alpha transcription factor network |
| 0.1 | 1.3 | PID_ARF6_DOWNSTREAM_PATHWAY | Arf6 downstream pathway |
| 0.1 | 3.1 | PID_A6B1_A6B4_INTEGRIN_PATHWAY | a6b1 and a6b4 Integrin signaling |
| 0.1 | 10.4 | PID_P53_DOWNSTREAM_PATHWAY | Direct p53 effectors |
| 0.1 | 2.3 | ST_T_CELL_SIGNAL_TRANSDUCTION | T Cell Signal Transduction |
| 0.1 | 1.0 | PID_INTEGRIN_A9B1_PATHWAY | Alpha9 beta1 integrin signaling events |
| 0.1 | 3.3 | PID_MTOR_4PATHWAY | mTOR signaling pathway |
| 0.1 | 1.5 | SIG_REGULATION_OF_THE_ACTIN_CYTOSKELETON_BY_RHO_GTPASES | Genes related to regulation of the actin cytoskeleton |
| 0.0 | 0.5 | PID_SYNDECAN_3_PATHWAY | Syndecan-3-mediated signaling events |
| 0.0 | 0.6 | ST_PHOSPHOINOSITIDE_3_KINASE_PATHWAY | PI3K Pathway |
| 0.0 | 0.6 | PID_PI3KCI_AKT_PATHWAY | Class I PI3K signaling events mediated by Akt |
| 0.0 | 1.7 | PID_CASPASE_PATHWAY | Caspase cascade in apoptosis |
| 0.0 | 1.9 | PID_AR_TF_PATHWAY | Regulation of Androgen receptor activity |
| 0.0 | 0.5 | PID_TRAIL_PATHWAY | TRAIL signaling pathway |
| 0.0 | 1.1 | PID_ATF2_PATHWAY | ATF-2 transcription factor network |
| 0.0 | 1.1 | PID_CDC42_PATHWAY | CDC42 signaling events |
| 0.0 | 0.3 | PID_HIF1A_PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
| 0.0 | 1.4 | PID_MYC_ACTIV_PATHWAY | Validated targets of C-MYC transcriptional activation |
Gene overrepresentation in C2:CP:REACTOME category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.9 | 5.8 | REACTOME_SEROTONIN_RECEPTORS | Genes involved in Serotonin receptors |
| 0.9 | 5.6 | REACTOME_TRANSLOCATION_OF_ZAP_70_TO_IMMUNOLOGICAL_SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
| 0.5 | 12.5 | REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB | Genes involved in PKA-mediated phosphorylation of CREB |
| 0.5 | 4.7 | REACTOME_CD28_DEPENDENT_VAV1_PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
| 0.5 | 7.6 | REACTOME_SIGNAL_REGULATORY_PROTEIN_SIRP_FAMILY_INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
| 0.4 | 15.3 | REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES | Genes involved in Ion transport by P-type ATPases |
| 0.4 | 12.7 | REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS | Genes involved in Adherens junctions interactions |
| 0.4 | 11.3 | REACTOME_NITRIC_OXIDE_STIMULATES_GUANYLATE_CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
| 0.3 | 4.5 | REACTOME_ACTIVATED_AMPK_STIMULATES_FATTY_ACID_OXIDATION_IN_MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
| 0.3 | 7.0 | REACTOME_REGULATION_OF_SIGNALING_BY_CBL | Genes involved in Regulation of signaling by CBL |
| 0.3 | 13.6 | REACTOME_BMAL1_CLOCK_NPAS2_ACTIVATES_CIRCADIAN_EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
| 0.3 | 3.3 | REACTOME_ROLE_OF_SECOND_MESSENGERS_IN_NETRIN1_SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
| 0.3 | 1.6 | REACTOME_IRAK2_MEDIATED_ACTIVATION_OF_TAK1_COMPLEX_UPON_TLR7_8_OR_9_STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
| 0.3 | 6.3 | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_IN_EMT_EPITHELIAL_TO_MESENCHYMAL_TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
| 0.2 | 1.9 | REACTOME_PRESYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
| 0.2 | 3.1 | REACTOME_REGULATION_OF_RHEB_GTPASE_ACTIVITY_BY_AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
| 0.2 | 13.2 | REACTOME_AMINO_ACID_AND_OLIGOPEPTIDE_SLC_TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
| 0.2 | 4.7 | REACTOME_SIGNALLING_TO_P38_VIA_RIT_AND_RIN | Genes involved in Signalling to p38 via RIT and RIN |
| 0.2 | 3.7 | REACTOME_GABA_A_RECEPTOR_ACTIVATION | Genes involved in GABA A receptor activation |
| 0.2 | 5.4 | REACTOME_METAL_ION_SLC_TRANSPORTERS | Genes involved in Metal ion SLC transporters |
| 0.2 | 1.0 | REACTOME_SIGNALING_BY_EGFR_IN_CANCER | Genes involved in Signaling by EGFR in Cancer |
| 0.2 | 0.6 | REACTOME_TRANSPORT_OF_RIBONUCLEOPROTEINS_INTO_THE_HOST_NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
| 0.2 | 4.6 | REACTOME_CHEMOKINE_RECEPTORS_BIND_CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
| 0.2 | 1.8 | REACTOME_ABACAVIR_TRANSPORT_AND_METABOLISM | Genes involved in Abacavir transport and metabolism |
| 0.2 | 1.6 | REACTOME_PYRIMIDINE_CATABOLISM | Genes involved in Pyrimidine catabolism |
| 0.2 | 1.8 | REACTOME_ERKS_ARE_INACTIVATED | Genes involved in ERKs are inactivated |
| 0.2 | 4.3 | REACTOME_PTM_GAMMA_CARBOXYLATION_HYPUSINE_FORMATION_AND_ARYLSULFATASE_ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
| 0.2 | 4.9 | REACTOME_G_BETA_GAMMA_SIGNALLING_THROUGH_PLC_BETA | Genes involved in G beta:gamma signalling through PLC beta |
| 0.2 | 1.7 | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | Genes involved in Degradation of the extracellular matrix |
| 0.1 | 3.6 | REACTOME_GPVI_MEDIATED_ACTIVATION_CASCADE | Genes involved in GPVI-mediated activation cascade |
| 0.1 | 2.0 | REACTOME_TRAF3_DEPENDENT_IRF_ACTIVATION_PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
| 0.1 | 2.5 | REACTOME_CRMPS_IN_SEMA3A_SIGNALING | Genes involved in CRMPs in Sema3A signaling |
| 0.1 | 1.4 | REACTOME_BASE_FREE_SUGAR_PHOSPHATE_REMOVAL_VIA_THE_SINGLE_NUCLEOTIDE_REPLACEMENT_PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
| 0.1 | 1.5 | REACTOME_TETRAHYDROBIOPTERIN_BH4_SYNTHESIS_RECYCLING_SALVAGE_AND_REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
| 0.1 | 1.5 | REACTOME_FORMATION_OF_FIBRIN_CLOT_CLOTTING_CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
| 0.1 | 2.3 | REACTOME_RAP1_SIGNALLING | Genes involved in Rap1 signalling |
| 0.1 | 4.3 | REACTOME_GLUCOSE_TRANSPORT | Genes involved in Glucose transport |
| 0.1 | 1.1 | REACTOME_CLASS_C_3_METABOTROPIC_GLUTAMATE_PHEROMONE_RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
| 0.1 | 0.7 | REACTOME_BILE_SALT_AND_ORGANIC_ANION_SLC_TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
| 0.1 | 1.9 | REACTOME_CHOLESTEROL_BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
| 0.1 | 0.2 | REACTOME_EICOSANOID_LIGAND_BINDING_RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
| 0.1 | 2.5 | REACTOME_LYSOSOME_VESICLE_BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
| 0.1 | 0.9 | REACTOME_GAP_JUNCTION_DEGRADATION | Genes involved in Gap junction degradation |
| 0.1 | 0.9 | REACTOME_CHYLOMICRON_MEDIATED_LIPID_TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
| 0.1 | 2.8 | REACTOME_VOLTAGE_GATED_POTASSIUM_CHANNELS | Genes involved in Voltage gated Potassium channels |
| 0.1 | 0.9 | REACTOME_NRIF_SIGNALS_CELL_DEATH_FROM_THE_NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
| 0.1 | 1.0 | REACTOME_METABOLISM_OF_POLYAMINES | Genes involved in Metabolism of polyamines |
| 0.1 | 1.3 | REACTOME_HS_GAG_DEGRADATION | Genes involved in HS-GAG degradation |
| 0.1 | 1.4 | REACTOME_FORMATION_OF_INCISION_COMPLEX_IN_GG_NER | Genes involved in Formation of incision complex in GG-NER |
| 0.1 | 0.2 | REACTOME_ACTIVATION_OF_IRF3_IRF7_MEDIATED_BY_TBK1_IKK_EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
| 0.1 | 0.6 | REACTOME_MRNA_DECAY_BY_3_TO_5_EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
| 0.1 | 1.4 | REACTOME_ACTIVATED_NOTCH1_TRANSMITS_SIGNAL_TO_THE_NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
| 0.1 | 2.6 | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
| 0.1 | 0.3 | REACTOME_PURINE_CATABOLISM | Genes involved in Purine catabolism |
| 0.1 | 0.9 | REACTOME_ERK_MAPK_TARGETS | Genes involved in ERK/MAPK targets |
| 0.1 | 0.6 | REACTOME_SLBP_DEPENDENT_PROCESSING_OF_REPLICATION_DEPENDENT_HISTONE_PRE_MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
| 0.0 | 5.0 | REACTOME_PEPTIDE_CHAIN_ELONGATION | Genes involved in Peptide chain elongation |
| 0.0 | 1.6 | REACTOME_GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
| 0.0 | 0.4 | REACTOME_E2F_ENABLED_INHIBITION_OF_PRE_REPLICATION_COMPLEX_FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
| 0.0 | 2.4 | REACTOME_CLASS_B_2_SECRETIN_FAMILY_RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
| 0.0 | 1.1 | REACTOME_CYTOSOLIC_TRNA_AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
| 0.0 | 2.7 | REACTOME_LOSS_OF_NLP_FROM_MITOTIC_CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
| 0.0 | 0.2 | REACTOME_REGULATION_OF_ORNITHINE_DECARBOXYLASE_ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
| 0.0 | 0.7 | REACTOME_FORMATION_OF_ATP_BY_CHEMIOSMOTIC_COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
| 0.0 | 1.4 | REACTOME_TRANSPORT_OF_VITAMINS_NUCLEOSIDES_AND_RELATED_MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
| 0.0 | 0.4 | REACTOME_SIGNALING_BY_PDGF | Genes involved in Signaling by PDGF |
| 0.0 | 2.4 | REACTOME_G_ALPHA_I_SIGNALLING_EVENTS | Genes involved in G alpha (i) signalling events |
| 0.0 | 0.2 | REACTOME_TANDEM_PORE_DOMAIN_POTASSIUM_CHANNELS | Genes involved in Tandem pore domain potassium channels |
| 0.0 | 0.9 | REACTOME_SIGNALING_BY_ROBO_RECEPTOR | Genes involved in Signaling by Robo receptor |
| 0.0 | 0.3 | REACTOME_SYNTHESIS_OF_PE | Genes involved in Synthesis of PE |
| 0.0 | 1.2 | REACTOME_MITOCHONDRIAL_PROTEIN_IMPORT | Genes involved in Mitochondrial Protein Import |
| 0.0 | 0.3 | REACTOME_IL_RECEPTOR_SHC_SIGNALING | Genes involved in Interleukin receptor SHC signaling |
| 0.0 | 0.8 | REACTOME_SMOOTH_MUSCLE_CONTRACTION | Genes involved in Smooth Muscle Contraction |
| 0.0 | 0.4 | REACTOME_ABCA_TRANSPORTERS_IN_LIPID_HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
| 0.0 | 0.8 | REACTOME_SPHINGOLIPID_DE_NOVO_BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
| 0.0 | 0.5 | REACTOME_BIOSYNTHESIS_OF_THE_N_GLYCAN_PRECURSOR_DOLICHOL_LIPID_LINKED_OLIGOSACCHARIDE_LLO_AND_TRANSFER_TO_A_NASCENT_PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
| 0.0 | 0.4 | REACTOME_PREFOLDIN_MEDIATED_TRANSFER_OF_SUBSTRATE_TO_CCT_TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
| 0.0 | 1.0 | REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION | Genes involved in MHC class II antigen presentation |
| 0.0 | 0.4 | REACTOME_TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
| 0.0 | 0.2 | REACTOME_NUCLEAR_SIGNALING_BY_ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
